Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,074.68
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1,075.01 (80)
Ask (Size)
1,075.99 (120)
Prev. Close
1,074.68
Today's Range
1,074.68 - 1,074.68
52wk Range
623.78 - 1,111.99
Shares Outstanding
956,580,893
Dividend Yield
0.56%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
Today 15:28 EST
In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position...
Via
TokenRing AI
Topics
Artificial Intelligence
The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
Today 14:51 EST
The landscape of biological science underwent a seismic shift in November 2024, when Google DeepMind, a subsidiary of Alphabet Inc. (NASDAQ: GOOGL), officially released the source code and model...
Via
TokenRing AI
Topics
Artificial Intelligence
Performance
YTD
N/A
N/A
1 Month
+1.6%
+1.6%
3 Month
+30.2%
+30.2%
6 Month
+37.9%
+37.9%
1 Year
+39.2%
+39.2%
More News
Read More
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
Today 14:13 EST
Via
MarketMinute
Topics
Intellectual Property
Navigating the Neutral Rate: Wall Street's 2026 Outlook Forecasts Growth Amidst AI Maturity
Today 14:10 EST
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
Today 10:12 EST
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy.
↗
Today 7:45 EST
Via
The Motley Fool
Topics
Artificial Intelligence
Where Will Pfizer Be in 5 Years?
↗
December 31, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026
↗
December 31, 2025
Via
MarketBeat
So Long, Warren. Buffett Leaves Astonishing Gains As He Steps Down As CEO.
↗
December 31, 2025
Via
Investor's Business Daily
Decoding Life’s Blueprint: How AlphaFold 3 is Redefining the Frontier of Medicine
December 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Bonds
The 2026 Earnings Gauntlet: Can Corporate Profits Justify Wall Street's High-Wire Act?
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Could This Potential Move Boost Eli Lilly's Prospects?
↗
December 31, 2025
Via
The Motley Fool
Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake
↗
December 31, 2025
Via
MarketBeat
Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report
↗
December 31, 2025
Via
Stocktwits
Topics
Economy
Government
The “Operating System of Life”: How AlphaFold 3 Redefined Biology and the Drug Discovery Frontier
December 30, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
S&P 500 Hovers at the Flatline: A Masterclass in Market Resilience or the Quiet Before a 2026 Storm?
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Why Novo Nordisk Stock Dropped on Monday
↗
December 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
December 30, 2025
Via
MarketMinute
Topics
ETFs
Economy
World Trade
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
ETFs
Should You Buy the iShares S&P 500 ETF Before 2026, Even With the Stock Market at an All-Time High?
↗
December 30, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Stocks
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Top gainers and losers in the S&P500 index during Monday's after-hours session.
↗
December 29, 2025
Via
Chartmill
Frequently Asked Questions
Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,074.68
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 12/31/25 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,028.02B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,028B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today